As the massive outbreak of Ebola virus disease (EVD) in west Africa wanes, it has become
increasingly clear that thousands of survivors have many sequelae, some of which might be …

Background Killed whole-cell oral cholera vaccines (kOCVs) are becoming a standard cholera
control and prevention tool. However, vaccine efficacy and direct effectiveness estimates …

Background . The conflict in Darfur, Sudan, was responsible for the displacement of 1.8 million
civilians. We investigated a large outbreak of hepatitis E virus (HEV) infection in Mornay …

Background . Hepatitis E virus (HEV) causes acute onset of jaundice and a high case-fatality
ratio in pregnant women. We provide a clinical description of hospitalized case patients and …

Background Literature reviews (LRs) identify, evaluate, and synthesize relevant papers to a
particular research question to advance understanding and support decision-making. …

Background The use of vaccines to prevent and control cholera is currently under debate.
Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization…

Background. Thousands of people have survived Ebola virus disease (EVD) during the
ongoing outbreak. However, data about the frequency and risk factors of long-term post-EVD …

Background Oral cholera vaccines represent a new effective tool to fight cholera and are
licensed as two-dose regimens with 2–4 weeks between doses. Evidence from previous …

Background Malaria treatment is recommended for patients with suspected Ebola virus
disease (EVD) in West Africa, whether systematically or based on confirmed malaria diagnosis. …

The Ebola epidemic in West Africa was stopped by an enormous concerted effort of local
communities and national and international organizations. It is not clear, however, how much …